MAGODENT Sp. z o.o. Szpital Onkologiczno-Kardiologiczny

Warsaw, Masovian Voivodeship 04-125

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Renal Cell

Studies at this site

• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed